"The pace is getting quicker, the more you do. Pharmaceutical multinational AstraZeneca has enlisted London-based healthtech start-up Umotif to create digital tools to capture data about people's use of its drugs and to monitor clinical trials. AstraZeneca described the deal as "financially significant". Umotif, which created the first-ever app to be prescribed by the NHS, allows people to submit anonymous information about their illness via their smartphone, with the data analysed by medical professionals. The company said it was working on a new version of its app, called Umogram, that would allow users to share more detailed health data, including details such as whether they had taken certain medicines or
Pharmaceutical multinational AstraZeneca has enlisted London-based healthtech start-up Umotif to create digital tools to capture data about people's use of its drugs and to monitor clinical trials. AstraZeneca described the deal as "financially significant". Umotif, which created the first-ever app to be prescribed by the NHS, allows people to submit anonymous information about their illness via their smartphone, with the data analysed by medical professionals. The company said it was working on a new version of its app, called Umogram, that would allow users to share more detailed health data, including details such as whether they had taken certain medicines or